Debate 1: Reducción del daño e IQOS. En contra
Medín, María Inés; Granda Orive, José Ignacio de.
Prev. tab
; 20(3): 83-84, jul.-sept. 2018. tab
Artículo en Español | IBECS (España) | ID: ibc-180992
Documentos relacionados
Comparative efficacy and safety of pharmacological interventions for smoking cessation in healthy adults: A network meta-analysis.
Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.
Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.
Nicotine-Free E-Cigarettes Might Promote Tobacco Smoking Reduction Better Than Nicotine Delivery Devices: Results of a Double-Blind Randomized Controlled Trial at 1 Year.
Should psychiatrists support the availability of nicotine e-cigarettes in Australia?
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial.
Varenicline for smoking reduction in smokers not yet ready to quit: A double-blind, proof-of-concept randomized clinical trial.
Offering smoking treatment to primary care patients in two Wisconsin healthcare systems: Who chooses smoking reduction versus cessation?
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults.